Enter your search textButton to start search

» Open Advanced Search

Hepatitis C

Useful Links

• Hepatitis C Home
• For Veterans and the Public
• For Health Care Providers
• Publications and Products
• Web Resources
• About Us

Management and Treatment of Hepatitis C Viral Infection Home > Providers' Home > Clinical Care > Guidelines > 2006 Recommendations Hepatitis C Home For Veterans and the Public For Health Care Providers - Policies and Reports - Clinical Care - Provider Education - Browse by Topic Publications and Products Web Resources About Us for Health Care Providers Management and Treatment of Hepatitis C Viral Infection Hepatitis C Resource Center Program National Hepatitis C Program Office October 2006 Note: These guidelines are for archival purposes only. For the latest recommendations, please refer to Update on the Management and Treatment of Hepatitis C Virus Infection, 2012. The definitive version of this article is available in Am J Gastroenterol 2006;101:2360-2378 (PDF version). Table of Contents ABSTRACT INTRODUCTION PRETREATMENT ASSESSMENTS Laboratory Testing Liver Biopsy Psychiatric Assessment Assessments for Substance Use Disorders Adherence Autoimmune Disorders Hepatitis A and B and Other Liver Diseases Pregnancy Ocular Evaluation Extrahepatic Manifestations of Hepatitis C Evaluation for Human Immunodeficiency Virus (HIV) Coinfection DEFINITIONS OF RESPONSE THERAPY FOR PREVIOUSLY UNTREATED PATIENTS Peginterferon Alfa plus Ribavirin Monotherapy with Peginterferon Alfa Interferon Alfa plus Ribavirin Predictors of Treatment Response to Peginterferon Alfa plus Ribavirin Duration of Treatment GROUPS WITH SPECIAL CONSIDERATIONS FOR THERAPY Patients with Compensated Cirrhosis Patients Who Have Failed to Respond or Have Relapsed with Prior HCV Therapy Patients with Minimal Histologic Evidence of Liver Disease Patients with Persistently Normal Serum Alt Patients with Genotype 4-6 Infection Patients >65 Years and/or with Significant Comorbidities Patients on Methadone Maintenance Patients with Ongoing Alcohol Use African Americans Patients with Body Mass Index >30 and Hepatic Steatosis Patients with HCV-HIV Coinfection Patients with Renal Disease including Hemodialysis Patients with Acute Hepatitis C Patients with Decompensated Cirrhosis Patients with a History of Solid Organ Transplantation MONITORING TREATMENT SAFETY AND EFFICACY Treatment Monitoring Dose Modifications GROWTH FACTORS SUMMARY OF CURRENT RECOMMENDATIONS CONCLUDING COMMENTS Contributors ABBREVIATIONS AND GLOSSARY OF TERMS TABLES REFERENCES Search this website Search tips > Browse by Topic +Browse by Topic ^ Epidemiology and Natural History Prevention and Transmission Testing and Counseling Clinical Management Treatment HIV Coinfection Hepatitis A and B Liver Cirrhosis Hepatocellular Carcinoma Liver Transplant Print entire document PDF version Share this page Related Resource Quicknotes (abbreviated recommendations) Hepatitis C Management and Treatment Algorithm Contents Table of Contents Abstract Introduction Pretreatment Assessments Definitions of Response Therapy for Previously Untreated Patients Groups with Special Considerations Monitoring Growth Factors Summary of Current Recommendations Concluding Comments Abbreviations and Glossary Tables